Efficacy of PJS-539 for Adult Patients With COVID-19.

NCT05008393 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

153

Enrollment

OTHER

Sponsor class

Conditions

Covid19
COVID-19 Pneumonia

Interventions

DRUG: PJS-539 Dose 1
DRUG: PJS-539 Dose 2
DRUG: Placebo

Sponsor

Hospital do Coracao

Collaborators

[object Object]